K Govind Babu
-
- Cancer Diagnosis and Treatment 3
-
- Chronic Lymphocytic Leukemia Research 6
-
- Chronic Myeloid Leukemia Treatments 3
- Multiple Myeloma Research and Treatments 2
-
- Head and Neck Cancer Studies 5
-
- Interpreting and Communication in Healthcare 4
-
- Lymphoma Diagnosis and Treatment 3
-
- Oral Health Pathology and Treatment 2
- Co-authors
- P.P. BapsyM. BabuA. BalakrishnanKC LakshmaiahHemant MalhotraPrashant KumarAnnapoorni RangarajanRamray Bhat
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (2 papers)Blood (2 papers)
- Partner nations
- IndiaUnited KingdomFrance
In The Last Decade
K Govind Babu
28 papers receiving 245 citations
Peers
Comparison fields: 5 of 65
- Oncology 124
- Cancer Research 63
- Gastroenterology 18
- Genetics 33
- Hematology 32
Countries citing papers authored by K Govind Babu
This map shows the geographic impact of K Govind Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Govind Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Govind Babu more than expected).
Fields of papers citing papers by K Govind Babu
This network shows the impact of papers produced by K Govind Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Govind Babu. The network helps show where K Govind Babu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K Govind Babu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 5 | |
| 4 | 2019 | 46 | |
| 5 | 2019 | 37 | |
| 6 | 2018 | 0 | |
| 7 | 2018 | 6 | |
| 8 | 2017 | 14 | |
| 9 | 2016 | 8 | |
| 10 | Ofatumumab (O) in combination with fludarabine (F) and cyclophosphamide (C) (OFC) vs. FC in patients with relapsed chronic lymphocytic leukaemia (CLL): results of the phase III study complement 2 | 2015 | 3 |
| 11 | 2015 | 3 | |
| 12 | 2015 | 11 | |
| 13 | 2014 | 8 | |
| 14 | 2014 | 5 | |
| 15 | 2014 | 3 | |
| 16 | Chronic Myeloid Leukemia with Variant Chromosomal Translocations: Results of Treatment with Imatinib Mesylate | 2013 | 2 |
| 17 | 2013 | 10 | |
| 18 | 2009 | 2 | |
| 19 | 2007 | 33 | |
| 20 | Cardiac tamponade--a rare manifestation of non-Hodgkin's lymphoma. | 1993 | 1 |
About K Govind Babu
K Govind Babu is a scholar working on Otorhinolaryngology, Genetics and Hematology, having authored 33 papers that have together received 250 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Head and Neck Cancer Studies (5 papers), Interpreting and Communication in Healthcare (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Oral Health Pathology and Treatment (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (124 citations), Cancer Research (63 citations) and Gastroenterology (18 citations). K Govind Babu has collaborated with scholars based in India, United Kingdom and France. Frequent co-authors include P.P. Bapsy, M. Babu, A. Balakrishnan, KC Lakshmaiah, Hemant Malhotra, Prashant Kumar, Annapoorni Rangarajan, Ramray Bhat, Erik W. Thompson and Virgile Viasnoff. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.